Transamerica Financial Advisors’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.59K Buy
+117
New +$1.4K ﹤0.01% 1365
2026
Q1
Sell
-41
Closed -$309 1937
2025
Q4
$291 Sell
41
-13
-24% -$103 ﹤0.01% 1469
2025
Q3
$572 Buy
54
+53
+5,300% +$520 ﹤0.01% 1273
2025
Q2
$6 Hold
1
﹤0.01% 563
2025
Q1
$1K Hold
1
﹤0.01% 524
2024
Q4
$1K Hold
1
﹤0.01% 517
2024
Q3
$1K Hold
1
﹤0.01% 520
2024
Q2
$1K Hold
1
﹤0.01% 495
2024
Q1
$1K Hold
1
﹤0.01% 540
2023
Q4
$1K Hold
1
﹤0.01% 534
2023
Q3
$1K Hold
1
﹤0.01% 558
2023
Q2
$1K Hold
1
﹤0.01% 528
2023
Q1
$1K Hold
1
﹤0.01% 512
2022
Q4
$1K Hold
1
﹤0.01% 587
2022
Q3
$1K Sell
1
-1
-50% -$30 ﹤0.01% 553
2022
Q2
$1K Buy
+2
New +$70 ﹤0.01% 567

Other funds holding OGN

Transamerica Financial Advisors's OGN Position: Q2 2026 in Review

Transamerica Financial Advisors opened a new position in Organon & Co (OGN) in Q2 2026: 117 shares worth $1.59K. The stake represents ﹤0.01% of the portfolio and ranks #1365 among its holdings. This is a return to the name: Transamerica Financial Advisors previously reported a position in OGN as recently as Q4 2025.

Transamerica Financial Advisors first reported a position in OGN in Q2 2022 and has held it in 16 quarters since. 631 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Transamerica Financial Advisors held 117 shares of Organon & Co worth $1.59K as of Q2 2026.
  • Organon & Co was a new Transamerica Financial Advisors position in Q2 2026.
  • Organon & Co made up ﹤0.01% of Transamerica Financial Advisors's portfolio in Q2 2026, its #1365 holding.
  • Transamerica Financial Advisors first reported a position in Organon & Co in Q2 2022 and has held it in 16 quarters since.
  • 631 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Transamerica Financial Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.